Stockscreener 앱 받기
10.59
1.03%
-0.1031
Evolent Health Inc 주식(EVH)의 최신 뉴스
1 Unprofitable Stock Worth Investigating and 2 to Question - Yahoo Finance
Evolent Health to Participate in Upcoming Conferences - Seeking Alpha
Evolent Health, Inc. (NYSE:EVH) Receives $17.71 Consensus Target Price from Brokerages - MarketBeat
Winners And Losers Of Q4: Evolent Health (NYSE:EVH) Vs The Rest Of The Healthcare Technology for Providers Stocks - Yahoo Finance
Unpacking Q4 Earnings: Omnicell (NASDAQ:OMCL) In The Context Of Other Healthcare Technology for Providers Stocks - The Globe and Mail
Press Release Distribution & PR Platform - ACCESS Newswire
Q4 Earnings Highs And Lows: Premier (NASDAQ:PINC) Vs The Rest Of The Healthcare Technology for Providers Stocks - The Globe and Mail
Evolent Health, Inc. to Release First Quarter 2019 Operating Results and Host Conference Call on Tuesday, May 7, 2019 - BioSpace
Evolent names Shawn Guertin as new independent nominee for election to its Board of Directors - The Malaysian Reserve
Evolent Health Nominates Shawn Guertin to Board - TipRanks
Evolent names Shawn Guertin as new independent nominee for election to its Board of Directors | EVH Stock News - GuruFocus
Evolent Names Shawn Guertin As New Independent Nominee For Election To Its Board Of Directors - marketscreener.com
Healthcare Finance Veteran Shawn Guertin Brings 40-Year Experience to Evolent Board Nomination - Stock Titan
Molina Healthcare, Encompass Health, RadNet, Evolent Health, and Ibotta Shares Are Falling, What You Need To Know - Yahoo Finance
Analysts’ Top Healthcare Picks: Evolent Health (EVH), Gilead Sciences (GILD) - The Globe and Mail
Evolent Health Insiders Placed Bullish Bets Worth US$1.35m - Yahoo
Evolent program achieves 20% reduction in use of low-value oncol - GuruFocus
Evolent program achieves 20% reduction in use of low-value oncology regimens - PR Newswire
Healthcare Breakthrough: Evolent Slashes Expensive Cancer Treatment Costs While Maintaining Care Quality - Stock Titan
Benign Growth For Evolent Health, Inc. (NYSE:EVH) Underpins Its Share Price - simplywall.st
Evolent To Release First Quarter 2025 Financial Results on Thurs - GuruFocus
Evolent Health (EVH) Price Target Lowered by Truist Analyst Amid Market Uncertainty | EVH Stock News - GuruFocus
Evolent To Release First Quarter 2025 Financial Results on Thursday, May 8, 2025 - The Malaysian Reserve
The Analyst Verdict: Evolent Health In The Eyes Of 16 Experts - Benzinga
1 Growth Stock to Stash and 2 to Keep Off Your Radar - The Globe and Mail
Evolent Health price target lowered to $14 from $15 at Truist - TipRanks
Truist Cuts Price Target on Evolent Health to $14 From $15, Keeps Buy Rating - marketscreener.com
Indo-Asian News Service - Indo-Asian News Service (IANS)
Medicare Advantage Rates Expected To Climb Over 5%: CMSAlignment Healthcare (NASDAQ:ALHC) - Benzinga
Analysts Set Evolent Health, Inc. (NYSE:EVH) Price Target at $17.71 - MarketBeat
KeyBanc sees PRVA acquisition of EVH’s MSSP as unlikely but instructive - Investing.com Australia
Evolent Health, Inc. (EVH): Among Stocks Insiders Were Buying In Q1 2025 - Yahoo
20 Stocks Insiders Were Buying In Q1 2025 - Insider Monkey
Is Evolent Health (EVH) About to Explode? - Insider Monkey
12 Stocks That Are About to Explode - Insider Monkey
Here’s What Challenged Evolent Health (EVH) Despite Strong Revenue Growth - Insider Monkey
Evolent Health (NYSE:EVH) shareholders have endured a 69% loss from investing in the stock a year ago - Yahoo Finance
When the Price of (EVH) Talks, People Listen - Stock Traders Daily
1 Healthcare Stock on Our Watchlist and 2 to Turn Down - The Globe and Mail
Evolent Health (EVH): Among Stocks Insiders Are Buying In March - Insider Monkey
Evolent Health Co-Founder Acquires 13% More Stock - simplywall.st
10 Stocks Insiders Are Buying In March - Insider Monkey
Q4 Earnings Review: Healthcare Technology for Providers Stocks Led by Phreesia (NYSE:PHR) - The Globe and Mail
Cardinal Health Adds Two Members to Its Board of Directors - HME Business
Commit To Buy Evolent Health At $7.50, Earn 22.1% Annualized Using Options - Nasdaq
Define Ventures Appoints Carolyn Magill as Venture Partner - Quantisnow
Healthcare Powerhouse Carolyn Magill Joins $800M Define Ventures Leadership Team - StockTitan
Evolent Health (NYSE:EVH) Given New $12.00 Price Target at JPMorgan Chase & Co. - Defense World
0.02%
0.69%
자본화:
|
볼륨(24시간):